Donna Piri Sandler
Nurse Practitioner · Manahawkin, NJNPI 1245757905
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 38.0% of the total. Reporting peaked in 2024 at $555 and has fallen 53.6% since, to $258 in 2025.
Across 132 payments — averaging $14.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$746
- Novo Nordisk$306
- GSK$183
- Lilly USA, LLC$168
- AstraZeneca$101
- Arbor Pharmaceuticals, Inc.$51
- plus $408 from 17 others
What the payments were for
- Food & beverage$1,963100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,963 in reported general payments places this provider in the 85th percentile of 2,138 nurse practitioner providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 29 | $22,655 |
| FarxigaDapagliflozin Propanediol | 24 | $18,512 |
| JardianceEmpagliflozin | 12 | $15,495 |
| XareltoRivaroxaban | 16 | $11,476 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 23 | $3,844 |
| Atorvastatin Calcium | 255 | $2,518 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 13 | $2,243 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 53 | $2,228 |
| Rosuvastatin Calcium | 67 | $1,703 |
| Levothyroxine Sodium | 150 | $1,533 |
| Montelukast Sodium | 107 | $1,232 |
| Metoprolol Succinate | 96 | $1,164 |
| Amlodipine Besylate | 168 | $1,008 |
| Omeprazole | 89 | $956 |
| Nebivolol Hcl | 19 | $942 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $101 | $18,51224 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,138 nurse practitioner providers in New Jersey.
Other nurse practitioner in Manahawkin
- Nancy BonnetMorristown$407K
- Vanessa CoppolaCloster$205K
- Olufunmilayo IloriUnion$133K
- Janice BeitzHaddon Heights$75K
- Adewale AdefowojuUnion$70K
- Sophia KimEnglewood$70K
- Elizabeth FletcherCamden$62K
- Lannae EwingLinwood$39K
- Beth SavageNew Brunswick$34K
- Tina OcchiutoMorristown$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.